A5101900667- Pancreatic and Hepatic Oncology Research
- Gallbladder and Bile Duct Disorders
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Liver Disease Diagnosis and Treatment
- Pancreatitis Pathology and Treatment
- Gastric Cancer Management and Outcomes
- Pediatric Hepatobiliary Diseases and Treatments
- Biliary and Gastrointestinal Fistulas
- Liver physiology and pathology
- Esophageal and GI Pathology
- Organ Transplantation Techniques and Outcomes
- Cancer, Lipids, and Metabolism
- Metastasis and carcinoma case studies
- Colorectal Cancer Surgical Treatments
- Gastrointestinal Tumor Research and Treatment
- Abdominal Trauma and Injuries
- Congenital Diaphragmatic Hernia Studies
- Cancer Mechanisms and Therapy
- Radiomics and Machine Learning in Medical Imaging
- Intestinal Malrotation and Obstruction Disorders
- Colorectal Cancer Screening and Detection
- Gastrointestinal disorders and treatments
- Ferroptosis and cancer prognosis
- RNA modifications and cancer
Sir Run Run Shaw Hospital
2016-2025
Zhejiang University
2016-2025
Weatherford College
2021
Total Rehab
2021
University of Oklahoma
2020
Oklahoma City University
2020
Mayo Clinic in Arizona
2020
University of Rochester Medical Center
2020
Ningbo University
2019
Ningbo Medical Center Lihuili Hospital
2019
Enhanced recovery after surgery (ERAS) has shown effectiveness in terms of reducing the hospital stay and cost associated with open liver resection. However, benefit ERAS patients undergoing laparoscopic resection is still unclear, clinical studies on this topic are limited. The program for was used a group 80 (ERAS group). results were compared those control 107 patients. All underwent primary endpoints postoperative stay, defined as number days from to discharge, hospitalization expense....
Liver resection is the first-line treatment for primary liver cancers, providing potential a cure. However, concerns about post-hepatectomy failure (PHLF), leading cause of death following extended resection, have restricted population eligible patients. Here, we engineered clinical-grade bioartificial (BAL) device employing human-induced hepatocytes (hiHeps) manufactured under GMP conditions. In porcine PHLF model, hiHep-BAL showed remarkable survival benefit. On top supportive function,...
Hepatocellular carcinoma (HCC) is a heterogeneous malignancy with gender-related differences in onset and course. Androgen receptor (AR), male hormone receptor, critical the initiation progression of HCC. The role AR HCC has been mechanistically characterized anti-AR therapies have developed, showing limited efficacy. Immunotherapy targeting immune checkpoint proteins may substantially improve clinical management mechanism by which influences state remains unclear. In this study, we...
Background & Aims: According to the stage of tumor, it's hard suitable predict prognosis for gallbladder cancer, especially node-negative cancer.Therefore, we aimed create a nomogram based on demographic and clinicopathologic characteristics estimate individualized potential impacts postoperative overall survival.Methods: 789 patients with cancer were selected from Surveillance, Epidemiology, End Results randomly divided into training internal validation group.Univariate multivariate...
BACKGROUND: Ileal pouch-anal anastomosis is the standard surgical treatment for ulcerative colitis. However, ileal carries a risk of anastomotic leakage following pouch reconstruction, which may lead to significant morbidity, additional surgeries, and, in many cases, dysfunctional pouch. This study aims introduce technique that enhances safety anastomosis. IMPACT OF INNOVATION: We present novel degradable stent-secured intra-pouch bypass designed minimize or leakage. By preventing direct...